How to Write a Periodic Benefit-Risk Evaluation Report
Turn an interval of accumulated safety data into a defensible benefit-risk conclusion.
What a how-to is not
A how-to is SPEQ’s practitioner method, not a procedure. It does not replace your own SOP, it is not a validated approach, and the judgement calls in it belong to your quality unit.
The Periodic Benefit-Risk Evaluation Report (PBRER) is a periodic re-examination of whether a product’s benefits still outweigh its risks in light of everything learned since approval. The common failure is to produce a data dump: line listings and tabulations with no evaluation attached. The report is judged on its reasoning, not its length.
- 1
Fix the data lock point and the reporting interval
Establish the international birth date and the data lock point, and confirm the interval and submission timetable applicable in each region. Every dataset in the report is cut to that lock point, and a mismatch between sections is one of the first things a reviewer notices.
- 2
Assemble the interval and cumulative datasets
Distinguish clearly between what occurred during the interval and what has accumulated since authorisation. Both are needed: the interval shows what is new, and the cumulative view shows whether something new is part of a pattern.
- 3
Summarise regulatory and study developments
Record actions taken for safety reasons, changes to reference safety information, and the status of ongoing and completed studies. This section establishes what the world already knows, so the evaluation is not written as though nothing had happened.
- 4
Evaluate signals and characterise risks
Report signals evaluated during the interval and their outcome, and characterise important identified and potential risks and missing information. Evaluation means reaching a position with a stated rationale — closing a signal is a conclusion that must be argued, not recorded.
- 5
Set the risks against the benefit
Restate the benefit in the authorised indication and weigh the risk characterisation against it. A benefit-risk statement that does not engage with the interval’s findings is the section reviewers most often send back.
- 6
State conclusions and the actions that follow
Close with an explicit conclusion on whether the benefit-risk balance remains favourable, and with any proposed changes to the reference safety information, the risk management plan, or the product information. A conclusion with no consequent action, where the data suggested one, invites the question of why not.
- !Line listings and tabulations presented with no evaluation — data supplied instead of judgement.
- !Interval and cumulative datasets cut to different dates, so sections silently disagree.
- !Signals reported as "under evaluation" interval after interval with no advancing rationale.
- !A favourable benefit-risk conclusion asserted without engaging the interval’s own findings.
How to Write a Periodic Benefit-Risk Evaluation Report: frequently asked questions
Common questions on write a periodic benefit-risk evaluation report.
What is the difference between interval and cumulative data?
Interval data covers what occurred in the reporting period; cumulative data covers everything since authorisation. The interval tells you what is new and the cumulative view tells you whether it is part of a pattern, which is why a report with only one of them cannot support a benefit-risk conclusion.
How does the data lock point affect the report?
It is the cut-off to which every dataset in the report is prepared, and it anchors the submission timetable. Sections prepared to different cut-offs will disagree with each other on counts, and that inconsistency undermines the credibility of the evaluation that rests on them.
What makes a benefit-risk conclusion defensible?
That it engages with the specific findings of the interval and states a rationale a reader can follow, including why no action was needed if none is proposed. A conclusion that restates the previous period without addressing new information reads as a template rather than an evaluation.